TIGIT Expression on Intratumoral Lymphocytes Correlates with Improved Prognosis in Oral Squamous Cell Carcinoma

(1) Background: T-cell immunoglobulin and ITIM domain (TIGIT) is a potential immunotherapeutic target in a variety of malignant entities, and antibody-based treatments are currently under investigation in clinical trials. While promising results were observed in patients with lung cancer, the role o...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichberger, Jonas, Spoerl, Silvia, Spanier, Gerrit, Erber, Ramona, Taxis, Juergen, Schuderer, Johannes, Ludwig, Nils, Fiedler, Mathias, Nieberle, Felix, Ettl, Tobias, Geppert, Carol I., Reichert, Torsten E., Spoerl, Steffen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775507/
https://www.ncbi.nlm.nih.gov/pubmed/36551992
http://dx.doi.org/10.3390/biomedicines10123236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775507/
https://www.ncbi.nlm.nih.gov/pubmed/36551992
http://dx.doi.org/10.3390/biomedicines10123236

Ejemplares similares